CEBP CTRC-AACR San Antonio Breast Cancer Symposium Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shibata, D.
Right arrow Articles by Weiss, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shibata, D.
Right arrow Articles by Weiss, L. M.

Cancer Epidemiology Biomarkers & Prevention, Vol 2, Issue 3 213-217, Copyright © 1993 by American Association for Cancer Research


ARTICLES

Epstein-Barr virus-associated gastric adenocarcinoma among Japanese Americans in Hawaii

D Shibata, D Hawes, GN Stemmermann and LM Weiss
Department of Pathology, Los Angeles County-University of Southern California Medical Center 90033.

This study confirms the observation that some gastric adenocarcinomas contain Epstein-Barr viral (EBV) sequences in their carcinoma cells. EBV sequences were detected by polymerase chain reaction and in situ hybridization in the tumors of 19 of 187 (10.2%) Japanese-American men and women living in Hawaii. The EBV-associated gastric cancers were more frequently present in men than in women: 14 of 99 (14.3%) men versus 5 of 88 (5.7%) women (P = 0.046). EBV type A was found in 17 of the 19 EBV-associated cancers, a finding consistent with the type A predominance in Japanese populations. Intestinal and diffuse-type tumors were both EBV-positive, and moderate to marked inflammation was usually present. The virus was not found in adjacent normal nonneoplastic mucosal cells or in mucosa showing intestinal metaplasia. EBV-associated tumors were found at stages 1 or 2 in 53% of cases, compared with 36% of the EBV-negative cancers (P = 0.13). The presence of EBV did not appear to influence survival. The relatively high incidence of gastric cancer compared to other EBV-associated tumors makes EBV-associated gastric cancer potentially one of the most common EBV-related tumors in the United States.


This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
Q N Vo, J Geradts, M L Gulley, D A Boudreau, J C Bravo, and B G Schneider
Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation
J. Clin. Pathol., September 1, 2002; 55(9): 669 - 675.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. G. Chu, Y.-Y. Chen, W.-g. Chen, and L. M. Weiss
No Direct Role for Epstein-Barr Virus in American Hepatocellular Carcinoma
Am. J. Pathol., October 1, 2001; 159(4): 1287 - 1292.
[Abstract] [Full Text]


Home page
Mol. Pathol.Home page
K Takada
Epstein-Barr virus and gastric carcinoma
Mol. Pathol., October 1, 2000; 53(5): 255 - 261.
[Abstract] [Full Text]


Home page
INT J SURG PATHOLHome page
G. D. Clark, Yoke Sun Lee, K.-W. Min, and S. T. Dunn
Epstein-Barr Virus in Gastric Carcinomas from Singapore
International Journal of Surgical Pathology, January 1, 1996; 4(3): 149 - 158.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.